Related Experiment Videos
Emerging therapeutic targets in bipolar mood disorder
Roberto B Sassi1, Jair C Soares
1Neurochemical Brain Imaging Laboratory, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, 3811 O'Hara St., Pittsburgh, Pennsylvania 15213, USA.
Expert Opinion on Therapeutic Targets
|January 24, 2003
Summary
Bipolar disorder treatments like lithium and valproate affect multiple brain pathways. Research into these mood stabilizers reveals potential new targets for more effective bipolar disorder therapies.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Bipolar disorder is a severe psychiatric illness with unclear causes.
- Lithium and valproate are primary treatments, but many patients show poor response.
- There is a significant need for novel therapeutic agents for bipolar disorder.
Purpose of the Study:
- To review current research on the biochemical and molecular mechanisms of lithium and valproate.
- To identify potential cellular targets for developing new mood stabilizers.
Main Methods:
- Review of existing scientific literature on mood stabilizer mechanisms.
- Analysis of studies investigating intracellular signal transduction pathways.
- Examination of research on neurotrophic and neuroprotective effects.
Main Results:
- Lithium and valproate modulate multiple neural biochemical pathways.
- Mood stabilizers impact intracellular signal transduction mechanisms.
- These drugs induce long-term changes in neural plasticity, including neurotrophic and neuroprotective effects, potentially involving transcription factors and gene expression.
Conclusions:
- Understanding the mechanisms of current mood stabilizers is crucial for developing improved treatments.
- Identifying novel molecular targets could lead to more effective therapies for bipolar disorder.
- Further research into cellular pathways offers promise for future pharmacological interventions.